Companies / Neurocrine Biosciences Inc / Activity
Activity — Neurocrine Biosciences Inc
192 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Gano Kyle CEO | Grant | Common Stock | $0 | +10K +6.82% | 156,193 0.15% of shares | low |
| Feb 13, 2026 | Gano Kyle CEO | Exercise | Common Stock | $0 | +3K +1.77% | 147,610 0.15% of shares | low |
| Feb 13, 2026 | Gano Kyle CEO | Exercise | Common Stock | $0 | +2K +1.56% | 146,254 0.14% of shares | low |
| Feb 12, 2026 | Gano Kyle CEO | Exercise | Common Stock | $0 | +5K +3.46% | 146,661 0.14% of shares | low |
| Jan 31, 2026 | Gano Kyle CEO | Exercise | Common Stock | $0 | +3K +2.08% | 143,334 0.14% of shares | low |
| Feb 13, 2026 | Lippoldt Darin Executive | Gift | Common Stock | $0 | -365 -0.66% | 54,729 0.05% of shares | low |
| Feb 13, 2026 | Lippoldt Darin Executive | Grant | Common Stock | $0 | +10K +19.74% | 60,472 0.06% of shares | low |
| Feb 13, 2026 | Lippoldt Darin Executive | Exercise | Common Stock | $0 | +2K +4.20% | 51,628 0.05% of shares | low |
| Feb 13, 2026 | Lippoldt Darin Executive | Exercise | Common Stock | $0 | +2K +4.15% | 50,634 0.05% of shares | low |
| Feb 12, 2026 | Lippoldt Darin Executive | Exercise | Common Stock | $0 | +2K +3.75% | 49,584 0.05% of shares | low |
| Jan 31, 2026 | Lippoldt Darin Executive | Exercise | Common Stock | $0 | +2K +5.08% | 49,127 0.05% of shares | low |
| Feb 13, 2026 | Gorman Kevin Charles Director | Grant | Common Stock | $0 | +64K +12.21% | 585,673 0.58% of shares | low |
| Feb 13, 2026 | Gorman Kevin Charles Director | Exercise | Common Stock | $0 | +5K +1.04% | 524,850 0.52% of shares | low |
| Feb 13, 2026 | Gorman Kevin Charles Director | Exercise | Common Stock | $0 | +6K +1.08% | 522,497 0.51% of shares | low |
| Jan 31, 2026 | Gorman Kevin Charles Director | Exercise | Common Stock | $0 | +5K +1.00% | 519,738 0.51% of shares | low |
| May 27, 2026 | Sharp Shalini Director | Grant | Restriced Stock Unit | — | +3K | 2,567 <0.01% of shares | low |
| May 21, 2026 | Sharp Shalini Director | Exercise | Restricted Stock Unit | — | -2K -100.00% | 0 0.00% of shares | low |
| May 27, 2026 | Rastetter William H Director | Grant | Restriced Stock Unit | — | +3K | 2,567 <0.01% of shares | low |
| May 21, 2026 | Rastetter William H Director | Exercise | Restricted Stock Unit | — | -3K -100.00% | 0 0.00% of shares | low |
| May 27, 2026 | Gorman Kevin Charles Director | Grant | Non-Qualified Stock Option | — | +5K | 5,248 <0.01% of shares | low |
| May 19, 2026 | Gorman Kevin Charles Director | Exercise | Non-Qualified Stock Option | — | -205K -100.00% | 0 0.00% of shares | low |
| May 27, 2026 | Poon Christine a Director | Grant | Restriced Stock Unit | — | +3K | 2,567 <0.01% of shares | low |
| May 21, 2026 | Poon Christine a Director | Exercise | Restricted Stock Unit | — | -3K -100.00% | 0 0.00% of shares | low |
| May 27, 2026 | Pops Richard F Director | Grant | Restriced Stock Unit | — | +3K | 2,567 <0.01% of shares | low |
| May 21, 2026 | Pops Richard F Director | Exercise | Restricted Stock Unit | — | -3K -100.00% | 0 0.00% of shares | low |
| May 15, 2026 | Pops Richard F Director | Exercise | Non-Qualified Stock Option | — | -15K -100.00% | 0 0.00% of shares | low |
| May 27, 2026 | Lyons Gary a Director | Grant | Non-Qualified Stock Option | — | +3K | 2,624 <0.01% of shares | low |
| May 27, 2026 | Lyons Gary a Director | Grant | Restriced Stock Unit | — | +1K | 1,284 <0.01% of shares | low |
| May 21, 2026 | Lyons Gary a Director | Exercise | Restricted Stock Unit | — | -2K -100.00% | 0 0.00% of shares | low |
| Jun 5, 2026 | Sherwin Stephen a Director | Exercise | Non-Qualified Stock Option | — | -10K -100.00% | 0 0.00% of shares | low |
| Jun 5, 2026 | Sherwin Stephen a Director | Exercise | Non-Qualified Stock Option | — | -15K -100.00% | 0 0.00% of shares | low |
| May 27, 2026 | Sherwin Stephen a Director | Grant | Restriced Stock Unit | — | +3K | 2,567 <0.01% of shares | low |
| May 21, 2026 | Sherwin Stephen a Director | Exercise | Restricted Stock Unit | — | -3K -100.00% | 0 0.00% of shares | low |
| May 27, 2026 | Morrow George J Director | Grant | Restriced Stock Unit | — | +3K | 2,567 <0.01% of shares | low |
| May 21, 2026 | Morrow George J Director | Exercise | Restricted Stock Unit | — | -3K -100.00% | 0 0.00% of shares | low |
| Feb 13, 2026 | Delaet Ingrid Executive | Grant | Restricted Stock Unit | — | +5K | 5,479 <0.01% of shares | low |
| Feb 13, 2026 | Delaet Ingrid Executive | Grant | Stock Option | — | +31K | 31,234 0.03% of shares | low |
| Feb 13, 2026 | Delaet Ingrid Executive | Exercise | Restricted Stock Unit | — | -1K -50.00% | 1,359 <0.01% of shares | low |
| Feb 13, 2026 | Delaet Ingrid Executive | Exercise | Restricted Stock Unit | — | -1K -33.33% | 2,802 <0.01% of shares | low |
| Feb 12, 2026 | Delaet Ingrid Executive | Exercise | Restricted Stock Unit | — | -2K -25.00% | 4,801 <0.01% of shares | low |
| Jan 31, 2026 | Delaet Ingrid Executive | Exercise | Restriced Stock Unit | — | -801 -100.00% | 0 0.00% of shares | low |
| Feb 13, 2026 | Boyer David W. Executive | Grant | Restricted Stock Unit | — | +5K | 5,479 <0.01% of shares | low |
| Feb 13, 2026 | Boyer David W. Executive | Grant | Stock Option | — | +31K | 31,234 0.03% of shares | low |
| Feb 13, 2026 | Boyer David W. Executive | Exercise | Restricted Stock Unit | — | -2K -49.99% | 1,812 <0.01% of shares | low |
| Feb 13, 2026 | Boyer David W. Executive | Exercise | Restricted Stock Unit | — | -2K -33.33% | 3,083 <0.01% of shares | low |
| Feb 12, 2026 | Boyer David W. Executive | Exercise | Restricted Stock Unit | — | -2K -25.00% | 4,801 <0.01% of shares | low |
| Jan 31, 2026 | Boyer David W. Executive | Exercise | Restriced Stock Unit | — | -2K -100.00% | 0 0.00% of shares | low |
| Feb 13, 2026 | Onyia Jude Executive | Grant | Restricted Stock Unit | — | +10K | 9,669 <0.01% of shares | low |
| Feb 13, 2026 | Onyia Jude Executive | Grant | Stock Option | — | +55K | 55,119 0.05% of shares | low |
| Feb 13, 2026 | Onyia Jude Executive | Exercise | Restricted Stock Unit | — | -3K -50.00% | 2,717 <0.01% of shares | low |